Teva launches generic schizophrenia, bipolar disorder drug

Generic version of Zyprexa Zydis introduced
Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Eli Lilly did make $65

Eli Lilly did make $65 billion on Zyprexa and they still expect to capture 20% of the US market as well as a billion year on Zyprexa XR.-

Association Between Zyprexa and Hyperglycemia.
There is concern Zyprexa,like other atypical antipsychotic drugs, has the potential to cause metabolic disorders, particularly hyperglycemia (excess sugar) and diabetes. Atypical antipsychotics cause the body to metabolize fat instead of carbohydrates, leading to insulin resistance to the excess carbohydrates. At the same time they promote fat accumulation.I was a patient back in 1996-2000 who was a subject of Eli Lilly's Zyprexa 'viva' Zyprexa' off label sales promotion.I was given it as an ineffective costly treatment for PTSD It gave me diabetes as a side effect.--Daniel Haszard

© 2012 Drug Store News. All Rights Reserved.